Sentence examples for comparative indications from inspiring English sources

Comparative indications were offered by impact hysteresis cycles and the integration of data between different enhanced vision methods, namely interferometric and IR thermographic techniques.

Such properties may give comparative indications of drug clearance by metabolism or sequestering by endogenous proteins.

Subsequently, the notion of a "communal ancestor" has been developed into a specific scenario [ 16, 19] that derived from the comparative-genomic indications that the enzymes of membrane biogenesis and the core DNA replication machineries in archaea and bacteria were non-homologous [ 18, 42].

The "goodness of fit" of the assay is, for comparative purposes, an indication of how closely the data points of the reference serum standard curve fit the 4-PL model.

An exploratory indication of comparative variation between hairs from the same subjects at the same time, and from between different subjects, was possible using the mean marker levels per hair.

Given potential differences in sample purity and composition, we suggest that the gel density method is likely to be a more reliable indication of comparative genomic DNA yield than spectrometry.

However, because androgens affect bone quality and quantity [ 40, 41], the use of surrogate markers, such as BMD, to assess bone effects of AIs might not provide a clear indication of comparative fracture risk.

In this work Gegenbaur stated that "the most important part of the business of comparative anatomy is to find indications of genetic connections in the organization of the animal body".

Its application for a comparative analysis between countries provides indications to enhance the effectiveness of RE-related policies for regional economic development.

These positive but preliminary indications of the comparative efficacy of methadone and Suboxone for treating opiate dependence now require replication in a well-powered, randomised controlled trial.

Both organizations evaluate submissions for new drugs and/or new clinical indications based on comparative clinical and cost-effectiveness, and then generate recommendations for funding.